Effect of the intercellular adhesion molecule E-cadherin on the prognosis of non-small cell lung cancer

Arkhiv Patologii

Volumn 75, Issue 5, 2013, Pages 30-33

  Kolesnik, A P ^a   Shevchenko, A I ^a   Tumansky, V A ^a   Evseev, A V ^a  

^a State Medical University   (Ukraine)

Author keywords

E cadherin; Non small cell lung cancer; Survival

Indexed keywords

CADHERIN; CELL ADHESION MOLECULE;

ADULT; AGED; ARTICLE; CANCER STAGING; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; LUNG NON SMALL CELL CANCER; LUNG TUMOR; LYMPH NODE METASTASIS; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; PROGNOSIS; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CADHERINS; CARCINOMA, NON-SMALL-CELL LUNG; CELL ADHESION MOLECULES; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS;

EID: 84889049126     PISSN: 00041955     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Mauro L. V, Dallurzo L., Smith D., Veloso M. J., Lastiri J., Vasallo B. et al. Prognostic factors in resected Stage I and II non-small lung cancer (NSCLC). Proc. Am. Assoc. Cancer Res. 2006;47:4540.
2. Kase S., Sugio K, Yamazaki K., Okamoto T., Yarn T., Sugimachi K. et al. Expression of Å-cadherin and b-catenin in human non-small cell lung cancer and the clinical significance. Clin. Cancer Res. 2000;6:4789-96.
3. Lin Q., Li M., Shen Z.-Y., Xiong L.-W., Pan X.-E, Gen J.-E et al. Prognostic impact of vascular endothelial growth factor-A and E-cadherin expression in completely resected pathologic stage I nonsmall cell lung cancer. Jpn. J. Clin. Oncol. 2010;40(7):670-6.
4. Thiery J. P. Epithelial-mesenchymal transitions in tumour progression. Nat. Rev. Cancer. 2002;2:442-54.
5. Asamura H., Goya T., Koshiishi Y, Sohara Y., Eguchi K, Mori M. et al. A Japanese Lung Cancer Registry study: prognosis of 13, 010 resected lung cancers. J. Thorac. Oncol. 2008;3:46-52.
6. Berx G., Cleton-Jansen A. M., Nollet F., De Leeuw W. J., Van De Vijver M., Comelisse C. et al. E-cadherin is a tumour/invasion suppressor gene mutated in human lobular breast cancers. EMBO J. 1995;14:6107-15.
7. Cavallaro U. N-cadherin as an invasion promoter a novel target for antitumor therapy? Curr. Opin. Invest. Drugs. 2004;5:1274-8.
8. Liu D., Huang C., Kameyama K., Hayashi E., Yamauchi A., Kobayashi S. et al. E-cadherin expression associated with differentiation and prognosis in patients with non-small cell lung cancer. Ann. Thorac. Surg. 2001;71:949-55.
9. Choia Y. S., Shima Y. M., Kim S.-H., Son D. S., Lee H.-S., Kim G. Y. et al. Prognostic significance of E-cadherin and b-catenin in resected stage I non-small cell lung cancer. Eur. J. Cardiothorac. Sun;. 2003;24:441-9.
10. Pirinen R. T., Hirvikoski P., Johansson R. T., Hollmen S., Kosma V. M. Reduced expression of alpha-catenin, beta-catenin, and gammacatenin is associated with high cell proliferative activity and poor differentiation in non-small cell lung cancer. J. Clin. Pathol. 2001;54:391-5.
11. Herbst R. S., Yano S., Kuniyasu H., Khuri F. R., Bucana C. D., Guo F. et al. Differential expression of E-cadherin and type IV collagenase genes predicts outcome in patients with stage I non-small cell lung cancer. Clin. Cancer Res. 2000;6:790-7.
12. Nieto M. A. The snail superfamily of zinc-finger transcription factors. Nat. Rev. 2002;3:155-66.
13. Pantel K, Passlick B., Vogt J., Stosiek P., Angstwurm M., Seen-Hibler R. et al. Reduced expression of plakoglobin indicates an unfavorable prognosis in subsets of patients with non-small-cell lung cancer. J. Clin. Oncol. 1998;16:1407-13.
14. Sato G., Saijo Y., Uchiyama B., Kumano N., Sugawara S., Fujimura S. et al. Prognostic value of nucleolar protein pl20 in patients with resected lung adenocarcinoma. J. Clin. Oncol. 1999;17:2721-7.
15. Wijnhoven B. P., Dinjens W. N., Pignatelli M. E-cadherin-catenin cell-cell adhesion complex and human cancer. Br. J. Surg. 2000;87:992-1005.
16. Milas I., Komaki R., Hachiya T., Bubb R. S., Ro J. Y, Langford L. et al. Association of VEGF, CD-34, E-cadherin and MMP-9 expression of the primary non-small cell lung cancer lesion with brain metastatic lesion. Proc. Am. Assoc. Cancer Res. 2004;45:1919.
17. Peinado H., Marin F., Cubillo E, Stark H. J., Fusenig N., Nieto M. A. et al. Snail and E47 repressors of E-cadherin induce distinct invasive and angiogenic properties in vivo. J. Cell Sci. 2004;117:2827-39.